CN Patent

CN111763211A — 拉罗替尼盐酸盐、制备方法与应用

Assigned to Anqing Duohui Biotechnology Co ltd · Expires 2020-10-13 · 6y expired

What this patent protects

本发明公开一种拉罗替尼盐酸盐,涉及药物化学技术领域,其结构式如下: 本发明还公开拉罗替尼盐酸盐的制备方法,包括以下步骤:将(3S)‑N‑[5‑[(2R)‑2‑(2,5‑二氟苯基)‑1‑吡咯烷基]吡唑并[1,5‑A]嘧啶‑3‑基]‑3‑羟基‑1‑吡咯烷甲酰胺溶解于醇类溶剂中,加入盐酸,降温并搅拌析出固体,过滤后,即制得拉罗替尼盐酸盐。本发明的有益效果在于:本发明制备方法简单,在现有拉罗替尼的基础上制备出拉罗替尼盐酸盐,稳定性良好,适合作为原料药形式用于制剂的研发和生产。

USPTO Abstract

本发明公开一种拉罗替尼盐酸盐,涉及药物化学技术领域,其结构式如下: 本发明还公开拉罗替尼盐酸盐的制备方法,包括以下步骤:将(3S)‑N‑[5‑[(2R)‑2‑(2,5‑二氟苯基)‑1‑吡咯烷基]吡唑并[1,5‑A]嘧啶‑3‑基]‑3‑羟基‑1‑吡咯烷甲酰胺溶解于醇类溶剂中,加入盐酸,降温并搅拌析出固体,过滤后,即制得拉罗替尼盐酸盐。本发明的有益效果在于:本发明制备方法简单,在现有拉罗替尼的基础上制备出拉罗替尼盐酸盐,稳定性良好,适合作为原料药形式用于制剂的研发和生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111763211A
Jurisdiction
CN
Classification
Expires
2020-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Anqing Duohui Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.